Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-796
Closed -$208K 195
2022
Q4
$208K Buy
+796
New +$213K 0.11% 187
2020
Q4
Sell
-915
Closed -$232K 186
2020
Q3
$232K Buy
915
+50
+6% +$12.4K 0.13% 156
2020
Q2
$204K Buy
+865
New +$197K 0.13% 154
2020
Q1
Sell
-864
Closed -$208K 154
2019
Q4
$208K Buy
+864
New +$190K 0.12% 159

Other funds holding AMGN

TFG Advisers's AMGN Position: Q1 2023 in Review

TFG Advisers sold out of Amgen (AMGN) in Q1 2023, closing a stake of 796 shares — an estimated $208K sold.

TFG Advisers first reported a position in AMGN in Q4 2019 and held it in 4 quarters. The position peaked at $232K in Q3 2020. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • TFG Advisers reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • TFG Advisers sold 796 Amgen shares in Q1 2023, an estimated $208K.
  • TFG Advisers first reported a position in Amgen in Q4 2019 and held it in 4 quarters.
  • TFG Advisers's Amgen position peaked at $232K in Q3 2020.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on TFG Advisers's 13F filing for Q1 2023, filed 2 May 2023.